Page last updated: 2024-11-08

pheophorbide a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

pheophorbide a: split product of chlorophyll obtained by saponification of pheophytin [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID253193
CHEMBL ID510103
CHEMBL ID2006244
CHEBI ID38257
SCHEMBL ID579034
SCHEMBL ID56439
MeSH IDM0101708

Synonyms (37)

Synonym
NCI60_041663
phaeophorbid-a
(2(2)r,17s,18s)-7-ethyl-2(1),2(2),17,18-tetrahydro-2(2)-(methoxycarbonyl)-3,8,13,17-tetramethyl-2(1)-oxo-12-ethenylcyclopenta[at]porphyrin-18-propanoic acid
phaeophorbid a
CHEBI:38257 ,
(3s,4s,21r)-9-ethenyl-14-ethyl-21-(methoxycarbonyl)-4,8,13,18-tetramethyl-20-oxo-3-phorbinepropanoic acid
3-[(3s,4s,21r)-14-ethyl-21-(methoxycarbonyl)-4,8,13,18-tetramethyl-20-oxo-9-vinylphorbin-3-yl]propanoic acid
3-[(3r,8z,13z,19z,21s,22s)-11-ethyl-3-(methoxycarbonyl)-12,17,21,26-tetramethyl-4-oxo-16-vinyl-7,23,24,25-tetraazahexacyclo[18.2.1.1~5,8~.1~10,13~.1~15,18~.0~2,6~]hexacosa-1(23),2(6),5(26),8,10(25),11,13,15,17,19-decaen-22-yl]propanoic acid
nsc-75783
pheophorbide a
15664-29-6
3-phorbinepropanoic acid, 9-ethenyl-14-ethyl-21-(methoxycarbonyl)-4,8,13,18-tetramethyl-20-oxo-, (3s,4s,21r)-
(3s-(3alpha,4beta,21beta))-14-ethyl-21-(methoxycarbonyl)-4,8,13,18-tetramethyl-20-oxo-9-vinylphorbine-3-propionic acid
einecs 239-738-5
C18021
CHEMBL510103
ccris 8091
ia2wni2ho2 ,
unii-ia2wni2ho2
(3s,4s)-9-ethenyl-14-ethyl-21-(methoxycarbonyl)-4,8,13,18-tetramethyl-20-oxo-3-phorbinepropanoic acid
SCHEMBL579034
SCHEMBL56439
NSFSLUUZQIAOOX-LDCXZXNSSA-N
CHEMBL2006244
pheophorbide a, aldrichcpr
phaeophorbide a
pheophorbide-a, >=90% (hplc)
phaeophorbide
Q63370
3-[(3r,21s,22s)-16-ethenyl-11-ethyl-4-hydroxy-3-methoxycarbonyl-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid
DTXSID10884550
pheophorbide a'
13-epi-phaeophorbide a
pheophorbide a (>80%) (mixture of diastereomers)
phaeophorbidea
CS-0092948
HY-125665

Research Excerpts

Overview

Pheophorbide a (Pa) is a chlorophyll degradation product in the green plant cells. Pa-mediated photodynamic therapy (PDT) reportedly exhibits antitumor activity against various malignancies.

ExcerptReferenceRelevance
"Pheophorbide a is a photosensitizer that may be promising for the treatment of leishmaniasis."( The photodynamic action of pheophorbide a induces cell death through oxidative stress in Leishmania amazonensis.
Caetano, W; da Silva Rodrigues, JH; de Oliveira Silva, S; Miranda, N; Nakamura, CV; Ueda-Nakamura, T; Volpato, H, 2017
)
1.47
"Pheophorbide a (Pa) is a chlorine-based photosensitizer, and Pa-mediated photodynamic therapy (PDT) reportedly exhibits antitumor activity against various malignancies. "( Apoptotic effect of pheophorbide a-mediated photodynamic therapy on DMBA/TPA-induced mouse papillomas.
Cha, IH; Cho, SB; Choi, EJ; Kim, J; Kim, KY; Zhang, X; Zheng, Z; Zhu, L, 2015
)
2.18
"Pheophorbide a (Pa) is a chlorophyll degradation product in the green plant cells, its antitumor effect was reported on a number of human cancer cells with PDT approach."( Pheophorbide a based photodynamic therapy induces apoptosis via mitochondrial-mediated pathway in human uterine carcinosarcoma.
Fong, WP; Fung, KP; Liu, XZ; Tang, PM; Zhang, DM, 2009
)
2.52
"Pheophorbide a is a clorophyll catabolite that recently has drawn the attention of several investigators for its potential in photodynamic therapy. "( The chlorophyll catabolite pheophorbide a as a photosensitizer for the photodynamic therapy.
Drioli, S; Rapozzi, V; Xodo, LE; Zacchigna, M; Zorzet, S, 2012
)
2.12
"Pheophorbide a (Pba) is a chlorophyll catabolite that has been proposed as photosensitizer in photodynamic therapy. "( The PDT activity of free and pegylated pheophorbide a against an amelanotic melanoma transplanted in C57/BL6 mice.
Drioli, S; Rapozzi, V; Xodo, LE; Zacchigna, M; Zorzet, S, 2013
)
2.1
"Pheophorbide a (Pa) is a chlorine-based photosensitizer derived from an ethnopharmacological herb, and our group recently synthesized Pa by the removal of a magnesium ion and a phytyl group from chlorophyll-a. "( Synthesized Pheophorbide a-mediated photodynamic therapy induced apoptosis and autophagy in human oral squamous carcinoma cells.
Ahn, MY; Ahn, SG; Kim, YC; Kwon, SM; Lee, J; Min, SK; Yoon, HE; Yoon, JH, 2013
)
2.21
"Pheophorbide a is a photocytotoxic agent. "( In-vitro photocytotoxicity of lysosomotropic immunoliposomes containing pheophorbide a with human bladder carcinoma cells.
Bergstrom, LC; Chernomorsky, SA; Hagen, IK; Poretz, RD; Vucenik, I, 1994
)
1.96

Effects

ExcerptReferenceRelevance
"Pheophorbide a (Pa) has been proposed to be a potential photosensitizer for the photodynamic therapy of human cancer. "( Pheophorbide a: a photosensitizer with immunostimulating activities on mouse macrophage RAW 264.7 cells in the absence of irradiation.
Bui-Xuan, NH; Chan, JY; Cheung, KK; Fung, KP; Jiang, JL; Tang, PM; Wong, CK, 2011
)
3.25

Toxicity

ExcerptReferenceRelevance
" In addition, as was shown previously, a conjugation of polyamines with several toxic agents led to an increased toxicity to cancer cells."( Conjugation of chlorins with spermine enhances phototoxicity to cancer cells in vitro.
Darmostuk, M; Drašar, P; Jurášek, M; Lengyel, K; Ruml, T; Rumlová, M; Zelenka, J, 2017
)
0.46

Compound-Compound Interactions

ExcerptReferenceRelevance
" Here we provide a comprehensive multi-isotope labelling-based strategy using fully labelled (13) C, (15) N and (34) S plant tissues, in combination with a fractionated metabolite extraction protocol."( Elemental formula annotation of polar and lipophilic metabolites using (13) C, (15) N and (34) S isotope labelling, in combination with high-resolution mass spectrometry.
Eckhardt, A; Giavalisco, P; Hesse, H; Hubberten, HM; Hummel, J; Köhl, K; Li, Y; Matthes, A; Segu, S; Willmitzer, L, 2011
)
0.37

Bioavailability

ExcerptReferenceRelevance
"The human ATP-binding cassette transporter, ABCG2, confers resistance to multiple chemotherapeutic agents and also affects the bioavailability of different drugs."( The calcium channel blockers, 1,4-dihydropyridines, are substrates of the multidrug resistance-linked ABC drug transporter, ABCG2.
Ambudkar, SV; Bates, SE; Robey, RW; Shukla, S, 2006
)
0.33
" These results demonstrated that the industrial preservation processes of peafreezing and canningas well as the cooking have a positive effect on the bioaccessibility and bioavailability of the chlorophyll pigments with respect to the FP sample, emphasizing CFZP with greater bioaccesibilty degree."( Digestive stability, micellarization, and uptake by Caco-2 human intestinal cell of chlorophyll derivatives from different preparations of pea (Pisum sativum L.).
Gallardo-Guerrero, L; Gandul-Rojas, B; Mínguez-Mosquera, MI, 2008
)
0.35
" Nevertheless, several problems, including low bioavailability and long-lasting cutaneous photosensitivity, have limited their clinical application."( Phototherapeutic effect of transformable peptides containing pheophorbide a on colorectal cancer.
Dong, X; Hu, P; Liu, M; Ni, J; Qu, C; Wang, K; Xu, Y; Yang, Y; Yin, D; Yin, X; Zhang, L; Zhang, Z, 2022
)
0.96

Dosage Studied

ExcerptRelevanceReference
" However, since the inhibition of transporter is not specific to cancer cells, a decrease in the cytotoxic drug dosing may be needed to prevent excess toxicity, thus undermining the potential benefit brought about by a drug efflux inhibitor."( Targeting the ABCG2-overexpressing multidrug resistant (MDR) cancer cells by PPARγ agonists.
To, KK; Tomlinson, B, 2013
)
0.39
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pathways (1)

PathwayProteinsCompounds
Chlorophyll b degradation04

Bioassays (23)

Assay IDTitleYearJournalArticle
AID614577Cellular uptake in human HeLa cells at 10 uM after 48 hrs by confocal microscopic analysis2011Bioorganic & medicinal chemistry, Sep-15, Volume: 19, Issue:18
Synthesis of pheophorbide-a conjugates with anticancer drugs as potential cancer diagnostic and therapeutic agents.
AID356997Cytostatic activity against rat HTC cells at 66 ug/ml2001Journal of natural products, Jul, Volume: 64, Issue:7
Cytotoxic pheophorbide-related compounds from Clerodendrum calamitosum and C. cyrtophyllum.
AID356993Selectivity for human KB-CPT cells to human KB cells2001Journal of natural products, Jul, Volume: 64, Issue:7
Cytotoxic pheophorbide-related compounds from Clerodendrum calamitosum and C. cyrtophyllum.
AID1479744Activity at human ABCG2 expressed in MDCK2 cells at 1 uM after 1 hr by flow cytometric method2018Journal of medicinal chemistry, 04-26, Volume: 61, Issue:8
New Inhibitors of Breast Cancer Resistance Protein (ABCG2) Containing a 2,4-Disubstituted Pyridopyrimidine Scaffold.
AID356995Cytostatic activity against rat HTC cells at 66 ug/ml under direct photoirradiation2001Journal of natural products, Jul, Volume: 64, Issue:7
Cytotoxic pheophorbide-related compounds from Clerodendrum calamitosum and C. cyrtophyllum.
AID356996Cytostatic activity against rat HTC cells at 33 ug/ml2001Journal of natural products, Jul, Volume: 64, Issue:7
Cytotoxic pheophorbide-related compounds from Clerodendrum calamitosum and C. cyrtophyllum.
AID356989Cytotoxicity against human MCF7 cells after 72 hrs by SRB assay2001Journal of natural products, Jul, Volume: 64, Issue:7
Cytotoxic pheophorbide-related compounds from Clerodendrum calamitosum and C. cyrtophyllum.
AID398515Selectivity index, ratio of CC50 for HOG.R5 cells to IC50 for HIV1 3B2003Journal of natural products, Feb, Volume: 66, Issue:2
Natural anti-HIV agents. Part IV. Anti-HIV constituents from Vatica cinerea.
AID1723083Substrate Activity at ABCG2 (unknown origin) over expressed in MCF7/MX cells at 0.5 uM incubated for 2 hrs by confocal laser scanning microscopic method
AID356985Cytotoxicity against human A549 cells after 72 hrs by SRB assay2001Journal of natural products, Jul, Volume: 64, Issue:7
Cytotoxic pheophorbide-related compounds from Clerodendrum calamitosum and C. cyrtophyllum.
AID356990Cytotoxicity against human SK-MEL cells after 72 hrs by SRB assay2001Journal of natural products, Jul, Volume: 64, Issue:7
Cytotoxic pheophorbide-related compounds from Clerodendrum calamitosum and C. cyrtophyllum.
AID398516Antiviral activity against HIV1 3B infected in human HOG.R5 assessed as inhibition of viral replication by microtiter assay2003Journal of natural products, Feb, Volume: 66, Issue:2
Natural anti-HIV agents. Part IV. Anti-HIV constituents from Vatica cinerea.
AID1071731Inhibition of soybean lipoxygenase at 100 uM2014Bioorganic & medicinal chemistry letters, Mar-01, Volume: 24, Issue:5
Lipoxygenase inhibitors derived from marine macroalgae.
AID356984Cytotoxicity against human KB cells after 72 hrs by SRB assay2001Journal of natural products, Jul, Volume: 64, Issue:7
Cytotoxic pheophorbide-related compounds from Clerodendrum calamitosum and C. cyrtophyllum.
AID356992Selectivity for human KB-VCR cells to human KB cells2001Journal of natural products, Jul, Volume: 64, Issue:7
Cytotoxic pheophorbide-related compounds from Clerodendrum calamitosum and C. cyrtophyllum.
AID1723084Substrate Activity at ABCG2 in human MCF7 cells at 0.5 uM incubated for 2 hrs by confocal laser scanning microscopic method
AID1070442Antiviral activity against HIV-1 3B/H9 infected in human HOG.R5 cells transfected with HIV1 LTR-GFP assessed as inhibition of viral replication at 10 ug/ml by fluorescence analysis2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Bioactive compounds from Vitex leptobotrys.
AID356987Cytotoxicity against human CAKI cells after 72 hrs by SRB assay2001Journal of natural products, Jul, Volume: 64, Issue:7
Cytotoxic pheophorbide-related compounds from Clerodendrum calamitosum and C. cyrtophyllum.
AID356991Selectivity for human KB-7d cells to human KB cells2001Journal of natural products, Jul, Volume: 64, Issue:7
Cytotoxic pheophorbide-related compounds from Clerodendrum calamitosum and C. cyrtophyllum.
AID356988Cytotoxicity against human 1A9 cells after 72 hrs by SRB assay2001Journal of natural products, Jul, Volume: 64, Issue:7
Cytotoxic pheophorbide-related compounds from Clerodendrum calamitosum and C. cyrtophyllum.
AID398517Cytotoxicity against human HOG.R5 cells2003Journal of natural products, Feb, Volume: 66, Issue:2
Natural anti-HIV agents. Part IV. Anti-HIV constituents from Vatica cinerea.
AID356986Cytotoxicity against human HCT8 cells after 72 hrs by SRB assay2001Journal of natural products, Jul, Volume: 64, Issue:7
Cytotoxic pheophorbide-related compounds from Clerodendrum calamitosum and C. cyrtophyllum.
AID356994Cytostatic activity against rat HTC cells at 33 ug/ml under direct photoirradiation2001Journal of natural products, Jul, Volume: 64, Issue:7
Cytotoxic pheophorbide-related compounds from Clerodendrum calamitosum and C. cyrtophyllum.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (269)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (5.20)18.7374
1990's31 (11.52)18.2507
2000's72 (26.77)29.6817
2010's126 (46.84)24.3611
2020's26 (9.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.42

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.42 (24.57)
Research Supply Index5.63 (2.92)
Research Growth Index5.03 (4.65)
Search Engine Demand Index50.99 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (36.42)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews6 (2.16%)6.00%
Case Studies2 (0.72%)4.05%
Observational0 (0.00%)0.25%
Other270 (97.12%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]